Literature DB >> 24710680

Is ambulatory blood pressure monitoring useful in patients with chronic autonomic failure?

Lucy Norcliffe-Kaufmann1, Horacio Kaufmann.   

Abstract

Management of blood pressure (BP) abnormalities in patients with autonomic failure is usually based on office BP readings. It is uncertain, whether office readings reflect actual BP's [corrected] during a typical day. Therefore, in 45 patients with autonomic failure, we compared office BP values during a tilt test with those captured on a 24-h BP [corrected] ambulatory monitor. Office BP values while supine predicted well the level of nighttime hypertension. However, in only 33% of patients, office values during tilt test accurately reflected hypotension during a typical day. Therefore, BP [corrected] ambulatory monitoring is useful to gauge the true severity of hypotension in patients with autonomic failure.

Entities:  

Mesh:

Year:  2014        PMID: 24710680     DOI: 10.1007/s10286-014-0229-y

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  6 in total

1.  Hypertensive cardiovascular damage in patients with primary autonomic failure.

Authors:  T D Vagaonescu; D Saadia; S Tuhrim; R A Phillips; H Kaufmann
Journal:  Lancet       Date:  2000-02-26       Impact factor: 79.321

2.  Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome.

Authors:  Roy Freeman; Wouter Wieling; Felicia B Axelrod; David G Benditt; Eduardo Benarroch; Italo Biaggioni; William P Cheshire; Thomas Chelimsky; Pietro Cortelli; Christopher H Gibbons; David S Goldstein; Roger Hainsworth; Max J Hilz; Giris Jacob; Horacio Kaufmann; Jens Jordan; Lewis A Lipsitz; Benjamin D Levine; Phillip A Low; Christopher Mathias; Satish R Raj; David Robertson; Paola Sandroni; Irwin Schatz; Ron Schondorff; Julian M Stewart; J Gert van Dijk
Journal:  Clin Auton Res       Date:  2011-04       Impact factor: 4.435

3.  Renal impairment of pure autonomic failure.

Authors:  Emily M Garland; Alfredo Gamboa; Luis Okamoto; Satish R Raj; Bonnie K Black; Thomas L Davis; Italo Biaggioni; David Robertson
Journal:  Hypertension       Date:  2009-09-08       Impact factor: 10.190

4.  Mineralocorticoid-induced hypertension in patients with orthostatic hypotension.

Authors:  A V Chobanian; L Volicer; C P Tifft; H Gavras; C S Liang; D Faxon
Journal:  N Engl J Med       Date:  1979-07-12       Impact factor: 91.245

5.  Developmental abnormalities, blood pressure variability and renal disease in Riley Day syndrome.

Authors:  L Norcliffe-Kaufmann; F B Axelrod; H Kaufmann
Journal:  J Hum Hypertens       Date:  2011-12-01       Impact factor: 3.012

Review 6.  24-hour blood pressure monitoring in the evaluation of supine hypertension and orthostatic hypotension.

Authors:  A Ahsan Ejaz; Amir Kazory; Marcelo E Heinig
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-12       Impact factor: 3.738

  6 in total
  20 in total

1.  Epidemiology, Diagnosis, and Management of Neurogenic Orthostatic Hypotension.

Authors:  Jose-Alberto Palma; Horacio Kaufmann
Journal:  Mov Disord Clin Pract       Date:  2017-03-16

Review 2.  Management of Supine Hypertension Complicating Neurogenic Orthostatic Hypotension.

Authors:  Jacquie Baker; Kurt Kimpinski
Journal:  CNS Drugs       Date:  2017-08       Impact factor: 5.749

3.  Neurogenic hypertension: introduction to the series.

Authors:  Jose-Alberto Palma
Journal:  Clin Auton Res       Date:  2018-07-17       Impact factor: 4.435

4.  Neurogenic Orthostatic Hypotension. Lessons From Synucleinopathies.

Authors:  Juan Francisco Idiaquez; Juan Idiaquez; Juan Carlos Casar; Italo Biaggioni
Journal:  Am J Hypertens       Date:  2021-03-11       Impact factor: 2.689

Review 5.  Orthostatic Circulatory Disorders: From Nosology to Nuts and Bolts.

Authors:  Michael Gutkin; Julian M Stewart
Journal:  Am J Hypertens       Date:  2016-04-01       Impact factor: 2.689

6.  Clinical Trials for Neurogenic Orthostatic Hypotension: A Comprehensive Review of Endpoints, Pitfalls, and Challenges.

Authors:  Jose-Alberto Palma; Horacio Kaufmann
Journal:  Semin Neurol       Date:  2020-09-09       Impact factor: 3.420

Review 7.  Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies.

Authors:  Jose-Alberto Palma; Horacio Kaufmann
Journal:  Mov Disord       Date:  2018-03       Impact factor: 10.338

Review 8.  Orthostatic Hypotension in Parkinson Disease.

Authors:  Jose-Alberto Palma; Horacio Kaufmann
Journal:  Clin Geriatr Med       Date:  2019-09-06       Impact factor: 3.076

9.  Droxidopa in neurogenic orthostatic hypotension.

Authors:  Horacio Kaufmann; Lucy Norcliffe-Kaufmann; Jose-Alberto Palma
Journal:  Expert Rev Cardiovasc Ther       Date:  2015-06-19

Review 10.  Diagnosis of multiple system atrophy.

Authors:  Jose-Alberto Palma; Lucy Norcliffe-Kaufmann; Horacio Kaufmann
Journal:  Auton Neurosci       Date:  2017-10-23       Impact factor: 3.145

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.